Clinical Trial Update: RADIQAL Study (Radiation Dose and Image Quality Trial) [NA]

View source ↗

Summary

The RADIQAL study, a trial evaluating radiation dose and image quality, is currently recruiting for coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Philips Clinical & Medical Affairs Global | Conditions: Coronary Artery Disease | NA | Status: RECRUITING